European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

David Coghill; Tobias Banaschewski; Michel Lecendreux; Cesar Soutullo; Mats Johnson; Alessandro Zuddas; Colleen Anderson; Richard Civil; Nicholas Higgins; Andrew Lyne; Liza Squires

doi:10.1016/j.euroneuro.2012.11.012

European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2012.11.012 ◽

2013 ◽

Vol 23 (10) ◽

pp. 1208-1218 ◽

Cited By ~ 71

Author(s):

David Coghill ◽

Tobias Banaschewski ◽

Michel Lecendreux ◽

Cesar Soutullo ◽

Mats Johnson ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Phase 3 ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text

Faculty Opinions recommendation of European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976565.793485491 ◽

2013 ◽

Author(s):

Philip Asherson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Phase 3 ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text

Psychiatric-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: A phase 3, randomized, double-blind, multicentre, parallel-group, placebo- and active-controlled, dose-optimized study in Europe

Neuropsychiatrie de l Enfance et de l Adolescence ◽

10.1016/j.neurenf.2012.04.685 ◽

2012 ◽

Vol 60 (5) ◽

pp. S263

Author(s):

M.L. Lecendreux ◽

R.W. Dittmann ◽

M. Gasior ◽

T. Banaschewski ◽

R. Civil ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Phase 3 ◽

Lisdexamfetamine Dimesylate ◽

Double Blind ◽

Hyperactivity Disorder ◽

Parallel Group ◽

Safety Outcomes

Download Full-text

Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents

Archives of Clinical Psychiatry (São Paulo) ◽

10.1590/0101-60830000000007 ◽

2014 ◽

Vol 41 (2) ◽

pp. 34-39 ◽

Cited By ~ 2

Author(s):

Paulo Mattos

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

CNS Drugs ◽

10.1007/s40263-017-0487-z ◽

2018 ◽

Vol 32 (1) ◽

pp. 85-95 ◽

Cited By ~ 7

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Caleb Bliss ◽

Brigitte Robertson ◽

Alessandro Zuddas

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cognitive Function ◽

Children And Adolescents ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽

Hyperactivity Disorder

Download Full-text

958 – Efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: effect of age, sex and baseline disease severity

European Psychiatry ◽

10.1016/s0924-9338(13)76104-2 ◽

2013 ◽

Vol 28 ◽

pp. 1 ◽

Cited By ~ 1

Author(s):

M. Lecendreux ◽

T. Banaschewski ◽

C. Soutullo ◽

M. Johnson ◽

A. Zuddas ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Disease Severity ◽

Attention Deficit ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder ◽

Disorder Effect ◽

Effect Of Age ◽

Baseline Disease Severity

Download Full-text

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

CNS Drugs ◽

10.1007/s40263-018-0514-8 ◽

2018 ◽

Vol 32 (5) ◽

pp. 455-467 ◽

Cited By ~ 6

Author(s):

Tobias Banaschewski ◽

Mats Johnson ◽

Peter Nagy ◽

Isabel Hernández Otero ◽

César A. Soutullo ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽

Hyperactivity Disorder

Download Full-text

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial

European Child & Adolescent Psychiatry ◽

10.1007/s00787-013-0421-y ◽

2013 ◽

Vol 23 (2) ◽

pp. 61-68 ◽

Cited By ~ 20

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Michel Lecendreux ◽

Alessandro Zuddas ◽

Ralf W. Dittmann ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Randomized Controlled Trial ◽

Children And Adolescents ◽

Attention Deficit ◽

Controlled Trial ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder ◽

Randomized Controlled

Download Full-text

P.7.d.013 Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(15)30919-6 ◽

2015 ◽

Vol 25 ◽

pp. S648

Author(s):

A. Zuddas ◽

T. Banaschewski ◽

P. Nagy ◽

C. Soutullo ◽

B. Yan ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Lisdexamfetamine Dimesylate ◽

Safety And Efficacy ◽

Hyperactivity Disorder

Download Full-text

P-339 - Effect of lisdexamfetamine dimesylate on functional impairment in children and adolescents with attention-deficit/hyperactivity disorder

European Psychiatry ◽

10.1016/s0924-9338(12)74506-6 ◽

2012 ◽

Vol 27 ◽

pp. 1

Author(s):

C.A. Soutullo ◽

T. Banaschewski ◽

M.L. Lecendreux ◽

R. Bloomfield ◽

P. Hodgkins ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Functional Impairment ◽

Attention Deficit ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text

EPA-1407 – The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

European Psychiatry ◽

10.1016/s0924-9338(14)78612-2 ◽

2014 ◽

Vol 29 ◽

pp. 1

Author(s):

D.R. Coghill ◽

T. Banaschewski ◽

M. Lecendreux ◽

C. Soutullo ◽

M. Johnson ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

European Studies ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text